LifeStance (Nasdaq: LFST) has tapped Dave Bourdon, its chief financial officer, to lead the company as CEO. The leadership change comes as the outpatient mental health provider signals plans to accelerate its merger and acquisition strategy and achieve profitability by 2026. The company’s outgoing CEO, Ken Burdick, will now move to the role of executive […]
Over the last few months, we’ve watched Optum pull back on behavioral health funding on multiple fronts. While substantive to the specific sectors impacted, it signals that previous worries about payers cutting back on behavioral health reimbursements are warranted. In short, that’s bad news. But it’s not unexpected. Why is that? Because payers are largely […]
LifeStance Health (Nasdaq: LFST) is overhauling its facilities with a new operating model — one that it hopes will strengthen its position ahead of what executives expect to be a rocky 2025. The outpatient mental health giant’s executives project that federal reimbursement rate cuts will challenge the company’s financial progress. LifeStance is banking on momentum […]
Behavioral health has had a series of small but laudable wins in the last few weeks. The Biden administration finalized new parity rules. Drug overdose deaths are on the decline. The Federal Reserve cut interest rates. And Fed observers are predicting additional rate cuts, too. Be still my nerdy behavioral health industry-observer heart: That’s quite […]
After a year and a half of scale-backs and tempered growth, LifeStance Health (Nasdaq: LFST) is planning a return to M&A. The target for that comeback: 2026. LifeStance is still completing processes designed to improve efficiency, David Bourdon, the company’s chief financial officer, said at the 22nd Annual Morgan Stanley Healthcare Conference on Wednesday. Along […]
Medication adherence is a critical issue for behavioral health providers. This is especially true for patients with serious mental illness. More than half of patients with schizophrenia are nonadherent to medication, and 50% of patients with depression and 44% of patients with bipolar disorder are nonadherent to medication, according to a meta-analysis. In order to […]
The behavioral health industry’s use of technology has lagged behind other segments of the health care sector. Two of the industry’s biggest providers want to change that track record. LifeStance Health Group Inc. (Nasdaq: LFST) and Acadia Healthcare (Nasdaq: ACHC) are taking different approaches to developing their digital strategies. However, both are exploring AI and […]
Collaborative care has gained significant traction in the behavioral health industry since its inception in the early 2000s. The care model, which integrates physical and behavioral health care services, is set to become the gold standard, according to Dr. Ujjwal Ramtekkar, chief medical officer of LifeStance Health. LifeStance is increasingly implementing collaborative care across its […]
All was relatively quiet on the behavioral health front for publicly traded companies in Q1, reflecting the typically sleepy nature of the first quarter for those seeking to wrap up old initiatives and start new ones. Don’t get me wrong: It’s not like nothing happened or there isn’t anything worth pondering. Quite the opposite, in […]
LifeStance Health Group Inc. (Nasdaq: LFST) faces the challenge of finding a successor for a departing top executive. Danish Qureshi, president and chief operating officer of LifeStance, announced his resignation on the company’s first-quarter earnings call. “For me, now is the right time to step away and take on my next challenge,” Qureshi said on […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
